Webinar: CAR T-cell Therapy for Lymphoma Patients in Manitoba

Webinar: CAR T-cell Therapy for Lymphoma Patients in Manitoba

372 372 people viewed this event.

CAR T-cell Therapy for Lymphoma Patients in Manitoba


Thursday, June 20th, 2024
4:00pm EST


CAR T-cell therapy is a novel treatment option for certain lymphoma patients who have relapsed or have a refractory response to multiple lines of treatment. In this webinar, Dr. Menard will delve into the revolutionary CAR T-cell therapy, discussing its applications, efficacy, availability and accessibility specifically for patients within Manitoba.


Dr. Chantalle Menard

Speaker Bio:

Dr. Menard is a hematologist at CancerCare Manitoba with a special interest in lymphoma, leukemia and bone marrow transplantation. Dr. Menard completed her medical degree and post-graduate training in Internal Medicine and Hematology at the University of Manitoba, as well as a fellowship in Advanced Training in Hematologic Malignancies. Dr. Menard obtained a Master of Science in Healthcare Quality through Queens University, and uses her knowledge in Quality Improvement to enhance care delivery and reduce diagnostic delays for patients with cancer in Manitoba. She provides clinical services within the Lymphoma, Leukemia and Bone Marrow Transplant Disease Site Groups.

To register for this event please visit the following URL: https://attendee.gotowebinar.com/register/2904108614790496349 →


Date And Time

20-06-24 @ 04:00 PM to


Online event

Event Category

Share With Friends